Notably, zinc pyrithione (ZnPT) targets SDCBP, restoring YAP1 degradation and suppressing tumour growth in PDX and PDO models, indicating the SDCBP–YAP1 axis as a promising therapeutic target for pancreatic cancer. Here, SDCBP is linked to familial pancreatic carcinoma.